Nutech Cancer Biomarkers India Private Limited offers SeroMark-1 test to detect prostate cancer (PCa) early in "normal appearing" men (age 40-65). Indian Council of Medical Research has projected increased cancer incidence among a total of 13,54,66,250 (age ≈40-65) Indian males in 2018. This is because there is no monitoring or screening for PCa in India. SeroMark-1 test (Rs 4000/test) is the only test that fulfills that urgent unmet need.